<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Penny, Hweixian Leong</dc:creator>
  <dc:creator>Sieow, Je Lin</dc:creator>
  <dc:creator>Gun, Sin Yee</dc:creator>
  <dc:creator>Lau, Mai Chan</dc:creator>
  <dc:creator>Lee, Bernett</dc:creator>
  <dc:creator>Tan, Jasmine</dc:creator>
  <dc:creator>Phua, Cindy</dc:creator>
  <dc:creator>Toh, Florida</dc:creator>
  <dc:creator>Nga, Yvonne</dc:creator>
  <dc:creator>Yeap, Wei Hseun</dc:creator>
  <dc:creator>Janela, Baptiste</dc:creator>
  <dc:creator>Kumar, Dilip</dc:creator>
  <dc:creator>Chen, Hao</dc:creator>
  <dc:creator>Yeong, Joe</dc:creator>
  <dc:creator>Kenkel, Justin A.</dc:creator>
  <dc:creator>Pang, Angela</dc:creator>
  <dc:creator>Lim, Diana</dc:creator>
  <dc:creator>Toh, Han Chong</dc:creator>
  <dc:creator>Hon, Tony Lim Kiat</dc:creator>
  <dc:creator>Johnson, Christopher I.</dc:creator>
  <dc:creator>Khameneh, Hanif Javanmard</dc:creator>
  <dc:creator>Mortellaro, Alessandra</dc:creator>
  <dc:creator>Engleman, Edgar G.</dc:creator>
  <dc:creator>Rotzschke, Olaf</dc:creator>
  <dc:creator>Ginhoux, Florent</dc:creator>
  <dc:creator>Abastado, Jean-Pierre</dc:creator>
  <dc:creator>Chen, Jinmiao</dc:creator>
  <dc:creator>Wong, Siew Cheng</dc:creator>
  <dc:date>2021-06-14</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Inflammation in the tumor microenvironment has been shown to promote disease progression in pancreatic ductal  adenocarcinoma (PDAC); however, the role of macrophage metabolism in promoting inflammation is unclear. Using an orthotopic  mouse model of PDAC, we demonstrate that macrophages from tumor-bearing mice exhibit elevated glycolysis. Macrophage- specific deletion of Glucose Transporter 1 (GLUT1) significantly reduced tumor burden, which was accompanied by increased  Natural Killer and CD8+ T cell activity and suppression of the NLRP3-IL1β inflammasome axis. Administration of mice with a  GLUT1-specific inhibitor reduced tumor burden, comparable with gemcitabine, the current standard-of-care. In addition, we  observe that intra-tumoral macrophages from human PDAC patients exhibit a pronounced glycolytic signature, which reliably  predicts poor survival. Our data support a key role for macrophage metabolism in tumor immunity, which could be exploited to  improve patient outcomes.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://localhost:5000/ark:/12658/srd1319350</dc:identifier>
  <dc:identifier>https://susi.usi.ch/global/documents/319350</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/319350/files/Khameneh_ijms_2021.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.3390/ijms22126350</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1319350</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>CC BY</dc:rights>
  <dc:source>International journal of molecular sciences. - MDPI. - 2021, vol. 22, no. 12, p. 24</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Pancreatic ductal adenocarcinoma</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Macrophage</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Immunometabolism</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Glycolysis</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/61</dc:subject>
  <dc:title xmlns:ns5="xml" ns5:lang="en">Targeting glycolysis in macrophages confers protection against pancreatic ductal adenocarcinoma</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
